Variant report

Variant	nsv518550
Chromosome Location	chr9:2618969-2621030
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:18)
CpG islands
(count:61)
Chromatin interactive
region (count:4)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:18 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CHD1	chr9:2620886-2622127	IMR90	lung:	n/a	n/a
2	CTCF	chr9:2620980-2621130	AG09319	gingival:	n/a	n/a
3	MAX	chr9:2620942-2624127	A549	lung:	n/a	chr9:2623485-2623494 chr9:2623484-2623495 chr9:2623484-2623495 chr9:2623668-2623678
4	MAZ	chr9:2620701-2624354	IMR90	lung:	n/a	chr9:2623485-2623494 chr9:2623484-2623495 chr9:2623484-2623495
5	MXI1	chr9:2621014-2623916	IMR90	lung:	n/a	n/a
6	MXI1	chr9:2619904-2624722	SK-N-SH	brain:	n/a	n/a
7	MYC	chr9:2621014-2622074	NB4	blood:	n/a	n/a
8	POLR2A	chr9:2620851-2623684	H1-neurons	neurons:	n/a	n/a
9	POLR2A	chr9:2621022-2622340	HL-60	blood:	n/a	n/a
10	POLR2A	chr9:2620818-2621959	H1-hESC	embryonic stem cell:	n/a	n/a
11	POLR2A	chr9:2620935-2623409	H1-neurons	neurons:	n/a	n/a
12	POLR2A	chr9:2620945-2622204	U87	brain:	n/a	n/a
13	POLR2A	chr9:2620945-2622528	U87	brain:	n/a	n/a
14	RCOR1	chr9:2620557-2622180	IMR90	lung:	n/a	n/a
15	REST	chr9:2620800-2623973	H1-neurons	neurons:	n/a	chr9:2621948-2621961 chr9:2622878-2622891 chr9:2621769-2621787 chr9:2621771-2621784 chr9:2622822-2622842
16	SIN3A	chr9:2620917-2624227	H1-hESC	embryonic stem cell:	n/a	chr9:2621427-2621438 chr9:2623544-2623553 chr9:2621915-2621924
17	TAF1	chr9:2620916-2622493	H1-neurons	neurons:	n/a	n/a
18	TBP	chr9:2620958-2621701	H1-hESC	embryonic stem cell:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:2619314-2619364	Caco-2	colon:	n/a
2	chr9:2619314-2619364	HCF	heart:	n/a
3	chr9:2619314-2619364	NHDF-neo	bronchial:	n/a
4	chr9:2619314-2619364	HepG2	liver:	n/a
5	chr9:2619314-2619364	BE2_C	brain:	n/a
6	chr9:2619314-2619364	HNPCEpiC	eye:	n/a
7	chr9:2619314-2619364	ECC-1	luminal epithelium:	n/a
8	chr9:2619314-2619364	GM12892	blood:	n/a
9	chr9:2619314-2619364	A549	lung:	n/a
10	chr9:2619314-2619364	HUVEC	blood vessel:	n/a
11	chr9:2619314-2619364	NB4	blood:	n/a
12	chr9:2619314-2619364	HEEpiC	esophagus:	n/a
13	chr9:2619314-2619364	U87	brain:	n/a
14	chr9:2619314-2619364	HCM	heart:	n/a
15	chr9:2619314-2619364	PFSK-1	brain:	n/a
16	chr9:2619314-2619364	HRE	kidney:	n/a
17	chr9:2619314-2619364	PANC-1	pancreas:	n/a
18	chr9:2619314-2619364	HMEC	breast:	n/a
19	chr9:2619314-2619364	GM06990	blood:	n/a
20	chr9:2619314-2619364	HRCEpiC	kidney:	n/a
21	chr9:2619314-2619364	SKMC	muscle:	n/a
22	chr9:2619314-2619364	HCPEpiC	choroid plexus:	n/a
23	chr9:2619314-2619364	RPTEC	kidney:	n/a
24	chr9:2619314-2619364	HIPEpiC	eye:	n/a
25	chr9:2619314-2619364	MCF10A-Er-Src	breast:	n/a
26	chr9:2619314-2619364	ProgFib	skin:	n/a
27	chr9:2619314-2619364	HPAEpiC	pulmonary alveolar:	n/a
28	chr9:2619314-2619364	SK-N-MC	brain:	n/a
29	chr9:2619314-2619364	SK-N-SH	brain:	n/a
30	chr9:2619314-2619364	AG10803	skin:	n/a
31	chr9:2619314-2619364	BJ	skin:	n/a
32	chr9:2619314-2619364	HAEpiC	amniotic membrane:	n/a
33	chr9:2619314-2619364	PrEC	prostate:	n/a
34	chr9:2619314-2619364	NT2-D1	testis:	n/a
35	chr9:2619314-2619364	GM12891	blood:	n/a
36	chr9:2619314-2619364	CMK	blood:	n/a
37	chr9:2619314-2619364	SK-N-SH_RA	brain:	n/a
38	chr9:2619314-2619364	IMR90	lung:	fetal
39	chr9:2619314-2619364	GM19239	blood:	n/a
40	chr9:2619314-2619364	GM12878	blood:	n/a
41	chr9:2619314-2619364	K562	blood:	n/a
42	chr9:2619314-2619364	AG04449	skin:	fetal
43	chr9:2619314-2619364	HL-60	blood:	n/a
44	chr9:2619314-2619364	Jurkat	blood:	n/a
45	chr9:2619314-2619364	AG09309	skin:	n/a
46	chr9:2619314-2619364	LNCaP	prostate:	n/a
47	chr9:2619314-2619364	AoSMC	blood vessel:	n/a
48	chr9:2619314-2619364	HRPEpiC	eye:	n/a
49	chr9:2619314-2619364	HEK293	kidney:	embryo
50	chr9:2619314-2619364	MCF-7	breast:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:2617041..2619621-chr9:2621235..2624621,3	MCF-7	breast:
2	chr9:2620987..2624573-chr9:2639977..2643677,3	MCF-7	breast:
3	chr9:2616577..2619117-chr9:2619974..2622873,2	MCF-7	breast:
4	chr9:2618162..2620045-chr9:2621820..2624612,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KIAA0020-1	chr9:2619998-2621792	NONHSAT130002

No data

Variant related genes	Relation type
VLDLR	TF binding region
VLDLR	CpG island
ENSG00000147852	chromatin interactions
ENSG00000236404	chromatin interactions

Extended variants
information (count: 89 )
Associated
traits (count: 107 )

Variant overlapped rSNPs/rCNVs (count:89 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4741746	chr9:2618969-2618970	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs72692558	chr9:2618972-2618973	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs555576632	chr9:2618991-2618992	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs146845588	chr9:2619003-2619004	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs563724933	chr9:2619012-2619013	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs12003385	chr9:2619016-2619017	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs191294429	chr9:2619030-2619031	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs540886045	chr9:2619046-2619047	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs183097825	chr9:2619051-2619052	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs188479225	chr9:2619079-2619080	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs542650413	chr9:2619096-2619097	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs76592480	chr9:2619105-2619106	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs531465454	chr9:2619130-2619131	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs551086163	chr9:2619142-2619143	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs75153622	chr9:2619178-2619179	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs74754400	chr9:2619190-2619191	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs142849600	chr9:2619227-2619228	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs547243007	chr9:2619253-2619254	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs566377636	chr9:2619254-2619255	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs567599107	chr9:2619268-2619269	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs535465155	chr9:2619311-2619312	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs549386703	chr9:2619315-2619316	Weak transcription Enhancers	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs528465131	chr9:2619329-2619330	Weak transcription Enhancers	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs1869589	chr9:2619333-2619334	Weak transcription Enhancers	CpG island Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs571728755	chr9:2619411-2619412	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs538307596	chr9:2619412-2619413	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs151066670	chr9:2619426-2619427	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs578181049	chr9:2619437-2619438	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs534439275	chr9:2619477-2619478	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs190675346	chr9:2619491-2619492	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs183346033	chr9:2619492-2619493	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs542239510	chr9:2619508-2619509	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs530466831	chr9:2619586-2619587	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs562478912	chr9:2619588-2619589	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs574337522	chr9:2619597-2619598	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs140919151	chr9:2619600-2619601	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs112965208	chr9:2619614-2619615	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs564643065	chr9:2619633-2619634	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs527480315	chr9:2619641-2619642	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs374790463	chr9:2619669-2619670	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs369490596	chr9:2619737-2619738	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs1869590	chr9:2619769-2619770	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs529972504	chr9:2619775-2619776	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs544183074	chr9:2619823-2619824	Weak transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs530948547	chr9:2619842-2619843	Weak transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs10967202	chr9:2619870-2619871	Weak transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs117386341	chr9:2619880-2619881	Weak transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs538244447	chr9:2619897-2619898	Weak transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs12057080	chr9:2619915-2619916	Weak transcription Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs35792530	chr9:2619930-2619931	Weak transcription Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:107)

Disease	PMID	Source
Gastric cancer	16715143	CNVD
Glioblastoma multiforme	22286061	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Disorders of sex development	21048976	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Myelofibrosis	22110671	CNVD
Developmental delay	21373258	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Hepatocellular carcinoma	18803288	CNVD
Schizophrenia	23813976	CNVD
Ovarian cancer	22355333	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Schizophrenia	20967226	CNVD
Ovarian cancer	21781307	CNVD
T-cell lymphomas	22341440	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:205 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:2614200-2621000	Weak transcription	Pancreas	Pancrea
2	chr9:2614200-2621200	Weak transcription	Lung	lung
3	chr9:2614400-2620600	Weak transcription	Right Atrium	heart
4	chr9:2614400-2621000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
5	chr9:2615800-2620000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
6	chr9:2616000-2619200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
7	chr9:2616000-2620000	Weak transcription	H1 Cell Line	embryonic stem cell
8	chr9:2616000-2620200	Weak transcription	Brain Angular Gyrus	brain
9	chr9:2616000-2620200	Weak transcription	Brain Hippocampus Middle	brain
10	chr9:2616000-2620200	Weak transcription	Brain Inferior Temporal Lobe	brain
11	chr9:2616000-2620200	Weak transcription	Brain Substantia Nigra	brain
12	chr9:2616200-2619200	Weak transcription	Ovary	ovary
13	chr9:2616400-2620600	Weak transcription	Fetal Stomach	stomach
14	chr9:2616600-2620200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
15	chr9:2616800-2619600	Weak transcription	H9 Cell Line	embryonic stem cell
16	chr9:2616800-2620800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
17	chr9:2616800-2621000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr9:2618800-2619400	Enhancers	Fetal Heart	heart
19	chr9:2619200-2619600	Enhancers	Ovary	ovary
20	chr9:2619200-2620600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
21	chr9:2619400-2620600	Weak transcription	Fetal Heart	heart
22	chr9:2619600-2619800	Enhancers	Fetal Brain Female	brain
23	chr9:2619600-2619800	Flanking Active TSS	Ovary	ovary
24	chr9:2619600-2620200	Active TSS	H9 Cell Line	embryonic stem cell
25	chr9:2619800-2624000	Active TSS	Ovary	ovary
26	chr9:2620000-2620200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
27	chr9:2620000-2620200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
28	chr9:2620000-2620200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
29	chr9:2620000-2620200	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
30	chr9:2620000-2620400	Flanking Active TSS	H1 Cell Line	embryonic stem cell
31	chr9:2620000-2620400	Bivalent/Poised TSS	Fetal Brain Female	brain
32	chr9:2620000-2620400	Enhancers	Pancreatic Islets	Pancreatic Islet
33	chr9:2620000-2620400	Enhancers	Dnd41	blood
34	chr9:2620000-2620600	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
35	chr9:2620000-2620600	Enhancers	Fetal Brain Male	brain
36	chr9:2620000-2620800	Enhancers	Brain Cingulate Gyrus	brain
37	chr9:2620000-2624000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
38	chr9:2620000-2624200	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr9:2620200-2620400	Flanking Active TSS	H9 Cell Line	embryonic stem cell
40	chr9:2620200-2620400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
41	chr9:2620200-2620400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
42	chr9:2620200-2620400	Enhancers	Brain Angular Gyrus	brain
43	chr9:2620200-2620400	Enhancers	Brain Inferior Temporal Lobe	brain
44	chr9:2620200-2620600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
45	chr9:2620200-2620600	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
46	chr9:2620200-2620600	Enhancers	Brain Germinal Matrix	brain
47	chr9:2620200-2620600	Enhancers	Brain Hippocampus Middle	brain
48	chr9:2620200-2620600	Active TSS	NHEK	skin
49	chr9:2620200-2620800	Enhancers	Breast Myoepithelial Primary Cells	Breast
50	chr9:2620200-2620800	Enhancers	Adipose Nuclei	Adipose

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links